Philips ultrasound upgrade targets breast imaging

Article

Enhancements in breast imaging mark the latest ultrasound upgrade from Philips Healthcare. Tissue aberration correction technology and algorithms built into the Vision 2009 upgrade for its iU22 radiological flagship are part of an integrated effort to better define tissue in fatty breasts, according to the company. An enabling technology is the Philips PureWave transducer and its coded beamformer, which have been present on earlier technologies.

Enhancements in breast imaging mark the latest ultrasound upgrade from Philips Healthcare. Tissue aberration correction technology and algorithms built into the Vision 2009 upgrade for its iU22 radiological flagship are part of an integrated effort to better define tissue in fatty breasts, according to the company. An enabling technology is the Philips PureWave transducer and its coded beamformer, which have been present on earlier technologies.

Tissue aberration correction, which was devised initially to look at obese patients, compensates for speed of sound variations of dense tissue, improving detail resolution and conspicuity of lesion details. Another major addition of Vision 2009 is the VL13-5 high-frequency volume linear transducer, which is clinically optimized for breast, thyroid, carotid, and general applications.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
Mammography Research: Can Adjunctive AI for DBT Provide Insight into Tumor Biology with Breast Cancer?
Diagnostic Imaging’s Weekly Scan: September 28 — October 4
Can Cardiopulmonary POCUS Enhance Detection and Management of Undifferentiated Dyspnea?
© 2025 MJH Life Sciences

All rights reserved.